Notable Facts
→Currently Chief Medical Officer at Amylyx Pharmaceuticals
→Previously CMO at Ultragenyx, Alexion, and ARIAD Pharmaceuticals
→Harvard MD and MIT MS degrees
→Nearly 30 years experience in rare disease drug development
→Board director at Crinetics and formerly Rhythm Pharmaceuticals
→Assistant Professor at Duke University Medical Center
→Member of MIT Corporation Visiting Committee
→Led development of Soliris for rare complement disorders
→Base salary of $575,000 at Amylyx
→500+ LinkedIn connections